Analysis of treatment adherence and cost among patients with epilepsy: a four‐year retrospective cohort study in Pakistan

Abstract

Background The adherence pattern of antiepileptic drugs (AEDs) among patients with epilepsy is relatively lower in the United States and different European countries. However, adherence and cost analysis of AEDs in Asian countries have not been thoroughly studied. Therefore, the present study aimed to analyze the cost and adherence of AEDs and its associated factors in patients followed in Pakistan. Methods Data from prescriptions collected from patients with epilepsy who have visited the Outpatient Department (OPD) of different tertiary care hospitals at the cosmopolitan city of Karachi, Pakistan from December 2015 to November 2019. The mean follow-up period for each participant was about 22 months. Pairwise comparisons from Cox regression/hazard ratios were used to assess the predictors of adherence. Direct costs of AEDs were calculated and presented as the annual cost of drugs. Results A total of 11,490 patients were included in this study, 51.2 % were male and 48.8 % were female with a mean age of 45.2 ± 15.8 y. Levetiracetam was found as the most prescribing AED in all study participants (32.9 %). Of them, 49.1 % of patients continued their initial recommended treatment. However, 31.3 % of patients have discontinued the therapy, while, 19.6 % were switched to other AED. Adherence with initial treatment was more profound in male (57.4 %) patients, compared to female with a mean age of 44.2 years. Lamotrigine users (60.6 %) showed a higher tendency to retain on initially prescribed drugs. The total cost of epilepsy treatment in the entire study cohort was 153280.5 PKR ($941.9). By applying the Cox regression analysis, it can be observed that the patients with increasing age (OR, 2.04), migraine (OR, 2.21), psychiatric disorders (OR, 4.28), other comorbidities (OR, 1.52) and users of other than top five prescribing AEDs (2.35) were at higher risk of treatment discontinuation. However, levetiracetam (OR, 0.69), valproic acid (OR, 0.52), carbamazepine (OR, 0.81), lamotrigine (OR, 0.80) or lacosamide (OR, 0.65) users have more chances to continue their initial therapy. Conclusions Similar to western countries, the majority of patients with epilepsy exhibited low adherence with AEDs. Various associated factors for improving adherence were identified in this study.

Impact of co-morbid common mental disorder symptoms in people with epilepsy in Ethiopia on quality of life and functional disability: cohort study

“…Previous studies have shown that people with CMD symptoms are less likely to be seizure free (8, 59). Common mental health conditions like depression have been found to contribute to treatment resistance epilepsy (59), poor treatment adherence (17,18), and increased anti-seizure medication side effects (7). Therefore, comorbid CMD symptoms could have directly contributed to poor anti-seizure medication adherence and side effects which then affected achieving seizure control.…”

“…In these settings, there is robust, high-quality evidence that people with epilepsy and comorbid CMD have increased risk of poor seizure control (8), premature mortality (9,10), anti-seizure medications side effects (7), poor quality of life (QoL) (6, [11][12][13][14] and increased functional disability (15,16). Comorbid CMDs and substance use have been associated with poor treatment adherence (17,18).…”

Clinico-etiological profile of children with seizures at a tertiary care centre in rural area in North India with special emphasis on “treatment gap”: a retrospective observational study

“…16 32% patients were dis continuers in a large retrospective cohort study from Pakistan. 17 Lack of public awareness, social stigma has been cited as common causes of treatment gap in resource limited settings. 18 Three most common reasons for inadequate treatment were trust on local spiritual babas for its cure (28%).…”

Fear of covid-19 and covid-19 anxiety as predictors of adherence to treatment in patients with epilepsy

“…They need to take daily antiepileptic drugs for years or throughout their lives. 4 The obvious benefits of antiepileptic drugs and the consequences of non-adherence to treatment may not be apparent immediately.…”